Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rare variants in XRCC2 as breast cancer susceptibility alleles.
Hilbers FS, Wijnen JT, Hoogerbrugge N, Oosterwijk JC, Collee MJ, Peterlongo P, Radice P, Manoukian S, Feroce I, Capra F, Couch FJ, Wang X, Guidugli L, Offit K, Shah S, Campbell IG, Thompson ER, James PA, Trainer AH, Gracia J, Benitez J, van Asperen CJ, Devilee P. Hilbers FS, et al. Among authors: hoogerbrugge n. J Med Genet. 2012 Oct;49(10):618-20. doi: 10.1136/jmedgenet-2012-101191. J Med Genet. 2012. PMID: 23054243
Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers.
van Roosmalen MS, Stalmeier PF, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Hoogerbrugge N, Moog U, van Daal WA. van Roosmalen MS, et al. Among authors: hoogerbrugge n. J Clin Oncol. 2004 Aug 15;22(16):3293-301. doi: 10.1200/JCO.2004.05.066. J Clin Oncol. 2004. PMID: 15310772 Free article. Clinical Trial.
Phenotypic expression of double heterozygosity for BRCA1 and BRCA2 germline mutations.
Leegte B, van der Hout AH, Deffenbaugh AM, Bakker MK, Mulder IM, ten Berge A, Leenders EP, Wesseling J, de Hullu J, Hoogerbrugge N, Ligtenberg MJ, Ardern-Jones A, Bancroft E, Salmon A, Barwell J, Eeles R, Oosterwijk JC. Leegte B, et al. Among authors: hoogerbrugge n. J Med Genet. 2005 Mar;42(3):e20. doi: 10.1136/jmg.2004.027243. J Med Genet. 2005. PMID: 15744030 Free PMC article. Review. No abstract available.
The decision evaluation scales.
Stalmeier PF, Roosmalen MS, Verhoef LC, Hoekstra-Weebers JE, Oosterwijk JC, Moog U, Hoogerbrugge N, van Daal WA. Stalmeier PF, et al. Among authors: hoogerbrugge n. Patient Educ Couns. 2005 Jun;57(3):286-93. doi: 10.1016/j.pec.2004.07.010. Patient Educ Couns. 2005. PMID: 15893210 Free article.
Multiplicity in polyp count and extracolonic manifestations in 40 Dutch patients with MYH associated polyposis coli (MAP).
Nielsen M, Franken PF, Reinards TH, Weiss MM, Wagner A, van der Klift H, Kloosterman S, Houwing-Duistermaat JJ, Aalfs CM, Ausems MG, Bröcker-Vriends AH, Gomez Garcia EB, Hoogerbrugge N, Menko FH, Sijmons RH, Verhoef S, Kuipers EJ, Morreau H, Breuning MH, Tops CM, Wijnen JT, Vasen HF, Fodde R, Hes FJ. Nielsen M, et al. Among authors: hoogerbrugge n. J Med Genet. 2005 Sep;42(9):e54. doi: 10.1136/jmg.2005.033217. J Med Genet. 2005. PMID: 16140997 Free PMC article.
Cancer risks in BRCA2 families: estimates for sites other than breast and ovary.
van Asperen CJ, Brohet RM, Meijers-Heijboer EJ, Hoogerbrugge N, Verhoef S, Vasen HF, Ausems MG, Menko FH, Gomez Garcia EB, Klijn JG, Hogervorst FB, van Houwelingen JC, van't Veer LJ, Rookus MA, van Leeuwen FE; Netherlands Collaborative Group on Hereditary Breast Cancer (HEBON). van Asperen CJ, et al. Among authors: hoogerbrugge n. J Med Genet. 2005 Sep;42(9):711-9. doi: 10.1136/jmg.2004.028829. J Med Genet. 2005. PMID: 16141007 Free PMC article.
Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: hoogerbrugge n. Clin Cancer Res. 2006 Mar 15;12(6):1693-700. doi: 10.1158/1078-0432.CCR-05-2230. Clin Cancer Res. 2006. PMID: 16551851
335 results